A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis

BACKGROUND: In trials conducted in India, recombinant granulocyte colony stimulating factor (GCSF) improved survival in alcohol-associated hepatitis (AH). The aim of this trial was to determine the safety and efficacy of pegfilgrastim, a long-acting recombinant GCSF, in patients with AH in the Unite...

Descripción completa

Detalles Bibliográficos
Autores principales: Tayek, John A., Stolz, Andrew A., Nguyen, Danh V., Fleischman, M. Wayne, Donovan, John A., Alcorn, Joseph M., Chao, Daniel C-K., Asghar, Aliya, Morgan, Timothy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576807/
https://www.ncbi.nlm.nih.gov/pubmed/36267499
http://dx.doi.org/10.1016/j.eclinm.2022.101689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576807/
https://www.ncbi.nlm.nih.gov/pubmed/36267499
http://dx.doi.org/10.1016/j.eclinm.2022.101689

Ejemplares similares